nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.439	1	CrCrCtD
Isoprenaline—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0875	0.538	CbGbCtD
Isoprenaline—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0752	0.462	CbGbCtD
Isoprenaline—Tachyarrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00336	0.0331	CcSEcCtD
Isoprenaline—Tachyarrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00311	0.0306	CcSEcCtD
Isoprenaline—Pallor—Tretinoin—peripheral nervous system neoplasm	0.00223	0.022	CcSEcCtD
Isoprenaline—Pallor—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.022	CcSEcCtD
Isoprenaline—Pallor—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.0167	CcSEcCtD
Isoprenaline—Pulmonary oedema—Tretinoin—peripheral nervous system neoplasm	0.00165	0.0162	CcSEcCtD
Isoprenaline—Pulmonary oedema—Isotretinoin—peripheral nervous system neoplasm	0.00165	0.0162	CcSEcCtD
Isoprenaline—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00129	0.0127	CcSEcCtD
Isoprenaline—Terbutaline—BCHE—peripheral nervous system neoplasm	0.00129	1	CrCbGaD
Isoprenaline—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00128	0.0126	CcSEcCtD
Isoprenaline—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.0126	CcSEcCtD
Isoprenaline—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00126	0.0124	CcSEcCtD
Isoprenaline—Pulmonary oedema—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.0123	CcSEcCtD
Isoprenaline—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00114	0.0113	CcSEcCtD
Isoprenaline—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.0113	CcSEcCtD
Isoprenaline—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00113	0.0111	CcSEcCtD
Isoprenaline—Sweating—Topotecan—peripheral nervous system neoplasm	0.001	0.00986	CcSEcCtD
Isoprenaline—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.000993	0.00978	CcSEcCtD
Isoprenaline—Sweating—Tretinoin—peripheral nervous system neoplasm	0.000993	0.00978	CcSEcCtD
Isoprenaline—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.000969	0.00954	CcSEcCtD
Isoprenaline—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000933	0.0092	CcSEcCtD
Isoprenaline—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.00853	CcSEcCtD
Isoprenaline—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000863	0.0085	CcSEcCtD
Isoprenaline—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.0085	CcSEcCtD
Isoprenaline—Flushing—Melphalan—peripheral nervous system neoplasm	0.000852	0.00839	CcSEcCtD
Isoprenaline—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000831	0.00818	CcSEcCtD
Isoprenaline—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000831	0.00818	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00083	0.00817	CcSEcCtD
Isoprenaline—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00082	0.00808	CcSEcCtD
Isoprenaline—Tension—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00783	CcSEcCtD
Isoprenaline—Tension—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00783	CcSEcCtD
Isoprenaline—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000786	0.00775	CcSEcCtD
Isoprenaline—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000786	0.00775	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.00756	CcSEcCtD
Isoprenaline—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00752	CcSEcCtD
Isoprenaline—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00752	CcSEcCtD
Isoprenaline—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000758	0.00747	CcSEcCtD
Isoprenaline—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000758	0.00747	CcSEcCtD
Isoprenaline—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000756	0.00745	CcSEcCtD
Isoprenaline—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000753	0.00741	CcSEcCtD
Isoprenaline—Sweating—Vincristine—peripheral nervous system neoplasm	0.000725	0.00714	CcSEcCtD
Isoprenaline—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000715	0.00705	CcSEcCtD
Isoprenaline—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000715	0.00705	CcSEcCtD
Isoprenaline—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000705	0.00695	CcSEcCtD
Isoprenaline—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000701	0.00691	CcSEcCtD
Isoprenaline—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000701	0.00691	CcSEcCtD
Isoprenaline—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000699	0.00689	CcSEcCtD
Isoprenaline—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000699	0.00689	CcSEcCtD
Isoprenaline—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000692	0.00682	CcSEcCtD
Isoprenaline—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.000676	0.00666	CcSEcCtD
Isoprenaline—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00644	CcSEcCtD
Isoprenaline—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000645	0.00635	CcSEcCtD
Isoprenaline—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000645	0.00635	CcSEcCtD
Isoprenaline—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000644	0.00634	CcSEcCtD
Isoprenaline—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000639	0.00629	CcSEcCtD
Isoprenaline—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.00629	CcSEcCtD
Isoprenaline—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000636	0.00627	CcSEcCtD
Isoprenaline—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.0062	CcSEcCtD
Isoprenaline—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000617	0.00608	CcSEcCtD
Isoprenaline—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000617	0.00608	CcSEcCtD
Isoprenaline—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000609	0.006	CcSEcCtD
Isoprenaline—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00593	CcSEcCtD
Isoprenaline—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000598	0.00589	CcSEcCtD
Isoprenaline—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000598	0.00589	CcSEcCtD
Isoprenaline—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000596	0.00587	CcSEcCtD
Isoprenaline—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000594	0.00585	CcSEcCtD
Isoprenaline—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000589	0.0058	CcSEcCtD
Isoprenaline—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000589	0.0058	CcSEcCtD
Isoprenaline—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000581	0.00573	CcSEcCtD
Isoprenaline—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.0057	CcSEcCtD
Isoprenaline—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00566	CcSEcCtD
Isoprenaline—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00549	CcSEcCtD
Isoprenaline—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000547	0.00538	CcSEcCtD
Isoprenaline—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000542	0.00534	CcSEcCtD
Isoprenaline—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000536	0.00528	CcSEcCtD
Isoprenaline—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000532	0.00524	CcSEcCtD
Isoprenaline—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000531	0.00523	CcSEcCtD
Isoprenaline—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.00522	CcSEcCtD
Isoprenaline—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000512	0.00505	CcSEcCtD
Isoprenaline—Flushing—Etoposide—peripheral nervous system neoplasm	0.000511	0.00503	CcSEcCtD
Isoprenaline—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00051	0.00503	CcSEcCtD
Isoprenaline—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.00498	CcSEcCtD
Isoprenaline—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000493	0.00485	CcSEcCtD
Isoprenaline—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00049	0.00482	CcSEcCtD
Isoprenaline—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.00481	CcSEcCtD
Isoprenaline—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00477	CcSEcCtD
Isoprenaline—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000478	0.00471	CcSEcCtD
Isoprenaline—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000474	0.00467	CcSEcCtD
Isoprenaline—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000474	0.00467	CcSEcCtD
Isoprenaline—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000468	0.00461	CcSEcCtD
Isoprenaline—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00461	CcSEcCtD
Isoprenaline—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000466	0.00459	CcSEcCtD
Isoprenaline—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000453	0.00446	CcSEcCtD
Isoprenaline—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00446	CcSEcCtD
Isoprenaline—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000451	0.00444	CcSEcCtD
Isoprenaline—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.0044	CcSEcCtD
Isoprenaline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00044	0.00434	CcSEcCtD
Isoprenaline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000437	0.0043	CcSEcCtD
Isoprenaline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.0043	CcSEcCtD
Isoprenaline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000436	0.0043	CcSEcCtD
Isoprenaline—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00043	0.00424	CcSEcCtD
Isoprenaline—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000424	0.00418	CcSEcCtD
Isoprenaline—Headache—Topotecan—peripheral nervous system neoplasm	0.000417	0.00411	CcSEcCtD
Isoprenaline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000416	0.0041	CcSEcCtD
Isoprenaline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000415	0.00409	CcSEcCtD
Isoprenaline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000414	0.00408	CcSEcCtD
Isoprenaline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000414	0.00408	CcSEcCtD
Isoprenaline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000413	0.00407	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000412	0.00406	CcSEcCtD
Isoprenaline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00393	CcSEcCtD
Isoprenaline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000396	0.0039	CcSEcCtD
Isoprenaline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000392	0.00387	CcSEcCtD
Isoprenaline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000392	0.00387	CcSEcCtD
Isoprenaline—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.00386	CcSEcCtD
Isoprenaline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000387	0.00382	CcSEcCtD
Isoprenaline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000387	0.00382	CcSEcCtD
Isoprenaline—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000381	0.00376	CcSEcCtD
Isoprenaline—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00375	CcSEcCtD
Isoprenaline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000378	0.00372	CcSEcCtD
Isoprenaline—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000375	0.0037	CcSEcCtD
Isoprenaline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000365	0.0036	CcSEcCtD
Isoprenaline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00354	CcSEcCtD
Isoprenaline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000348	0.00343	CcSEcCtD
Isoprenaline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00342	CcSEcCtD
Isoprenaline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000346	0.00341	CcSEcCtD
Isoprenaline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00326	CcSEcCtD
Isoprenaline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000329	0.00324	CcSEcCtD
Isoprenaline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000321	0.00316	CcSEcCtD
Isoprenaline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000319	0.00314	CcSEcCtD
Isoprenaline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00309	CcSEcCtD
Isoprenaline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00302	CcSEcCtD
Isoprenaline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.003	CcSEcCtD
Isoprenaline—Headache—Vincristine—peripheral nervous system neoplasm	0.000302	0.00298	CcSEcCtD
Isoprenaline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00293	CcSEcCtD
Isoprenaline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000287	0.00282	CcSEcCtD
Isoprenaline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00282	CcSEcCtD
Isoprenaline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00028	0.00276	CcSEcCtD
Isoprenaline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00271	CcSEcCtD
Isoprenaline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00261	CcSEcCtD
Isoprenaline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000263	0.0026	CcSEcCtD
Isoprenaline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00257	CcSEcCtD
Isoprenaline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000258	0.00255	CcSEcCtD
Isoprenaline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00251	CcSEcCtD
Isoprenaline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000253	0.0025	CcSEcCtD
Isoprenaline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00249	CcSEcCtD
Isoprenaline—Headache—Etoposide—peripheral nervous system neoplasm	0.000245	0.00241	CcSEcCtD
Isoprenaline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.0024	CcSEcCtD
Isoprenaline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00238	CcSEcCtD
Isoprenaline—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00238	CcSEcCtD
Isoprenaline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00234	CcSEcCtD
Isoprenaline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00231	CcSEcCtD
Isoprenaline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00229	CcSEcCtD
Isoprenaline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000232	0.00229	CcSEcCtD
Isoprenaline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00228	CcSEcCtD
Isoprenaline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.0022	CcSEcCtD
Isoprenaline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00216	CcSEcCtD
Isoprenaline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00212	CcSEcCtD
Isoprenaline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00211	CcSEcCtD
Isoprenaline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00211	CcSEcCtD
Isoprenaline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00209	CcSEcCtD
Isoprenaline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00202	CcSEcCtD
Isoprenaline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00195	CcSEcCtD
Isoprenaline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00195	CcSEcCtD
Isoprenaline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00193	CcSEcCtD
Isoprenaline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00192	CcSEcCtD
Isoprenaline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00187	CcSEcCtD
Isoprenaline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00181	CcSEcCtD
Isoprenaline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00178	CcSEcCtD
Isoprenaline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00155	CcSEcCtD
Isoprenaline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00143	CcSEcCtD
Isoprenaline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00143	CcSEcCtD
Isoprenaline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00135	CcSEcCtD
Isoprenaline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00132	CcSEcCtD
Isoprenaline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00128	CcSEcCtD
Isoprenaline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00125	CcSEcCtD
Isoprenaline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00119	CcSEcCtD
Isoprenaline—MAPK1—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	2.83e-05	9.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTPN11—peripheral nervous system neoplasm	2.83e-05	9.55e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.81e-05	9.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.81e-05	9.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.81e-05	9.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—ERBB2—peripheral nervous system neoplasm	2.8e-05	9.47e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.79e-05	9.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.79e-05	9.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.79e-05	9.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SLC2A1—peripheral nervous system neoplasm	2.79e-05	9.41e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTPN11—peripheral nervous system neoplasm	2.79e-05	9.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—NRAS—peripheral nervous system neoplasm	2.76e-05	9.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GNAS—peripheral nervous system neoplasm	2.76e-05	9.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—AKT1—peripheral nervous system neoplasm	2.74e-05	9.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.72e-05	9.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.72e-05	9.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.71e-05	9.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—peripheral nervous system neoplasm	2.69e-05	9.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.66e-05	8.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.65e-05	8.96e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	2.65e-05	8.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.64e-05	8.92e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.59e-05	8.76e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.59e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.58e-05	8.72e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.58e-05	8.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—HRAS—peripheral nervous system neoplasm	2.57e-05	8.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	2.56e-05	8.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.56e-05	8.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—NRAS—peripheral nervous system neoplasm	2.56e-05	8.66e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	2.54e-05	8.58e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.53e-05	8.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.53e-05	8.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.52e-05	8.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.52e-05	8.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	2.51e-05	8.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.49e-05	8.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	2.49e-05	8.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.48e-05	8.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—PTPN11—peripheral nervous system neoplasm	2.48e-05	8.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	2.46e-05	8.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	2.46e-05	8.31e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.46e-05	8.3e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	2.45e-05	8.26e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.44e-05	8.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.42e-05	8.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ERBB2—peripheral nervous system neoplasm	2.42e-05	8.18e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—ERBB2—peripheral nervous system neoplasm	2.38e-05	8.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.38e-05	8.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.33e-05	7.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.31e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HGF—peripheral nervous system neoplasm	2.31e-05	7.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—NRAS—peripheral nervous system neoplasm	2.31e-05	7.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.31e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTPN11—peripheral nervous system neoplasm	2.29e-05	7.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.29e-05	7.73e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.28e-05	7.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.28e-05	7.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	2.27e-05	7.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—AKT1—peripheral nervous system neoplasm	2.27e-05	7.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.26e-05	7.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.25e-05	7.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ERBB2—peripheral nervous system neoplasm	2.23e-05	7.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	2.23e-05	7.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.22e-05	7.51e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.21e-05	7.48e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ERBB2—peripheral nervous system neoplasm	2.2e-05	7.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—peripheral nervous system neoplasm	2.18e-05	7.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—NRAS—peripheral nervous system neoplasm	2.13e-05	7.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.1e-05	7.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—HRAS—peripheral nervous system neoplasm	2.08e-05	7.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.04e-05	6.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—HRAS—peripheral nervous system neoplasm	2.02e-05	6.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.02e-05	6.81e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.01e-05	6.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MYC—peripheral nervous system neoplasm	1.99e-05	6.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.99e-05	6.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.98e-05	6.69e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.97e-05	6.66e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.97e-05	6.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	6.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.96e-05	6.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERBB2—peripheral nervous system neoplasm	1.96e-05	6.63e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.95e-05	6.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.93e-05	6.54e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.9e-05	6.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.87e-05	6.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.85e-05	6.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.85e-05	6.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—NRAS—peripheral nervous system neoplasm	1.84e-05	6.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.84e-05	6.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—NRAS—peripheral nervous system neoplasm	1.81e-05	6.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB2—peripheral nervous system neoplasm	1.81e-05	6.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.8e-05	6.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.8e-05	6.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.79e-05	6.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.79e-05	6.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	6.02e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.75e-05	5.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.74e-05	5.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.71e-05	5.78e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—MYC—peripheral nervous system neoplasm	1.7e-05	5.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NRAS—peripheral nervous system neoplasm	1.7e-05	5.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HRAS—peripheral nervous system neoplasm	1.69e-05	5.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PTPN11—peripheral nervous system neoplasm	1.69e-05	5.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NRAS—peripheral nervous system neoplasm	1.67e-05	5.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.65e-05	5.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	5.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.63e-05	5.52e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.61e-05	5.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.6e-05	5.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.59e-05	5.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.59e-05	5.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MYC—peripheral nervous system neoplasm	1.58e-05	5.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.57e-05	5.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.57e-05	5.3e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.57e-05	5.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.56e-05	5.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—HRAS—peripheral nervous system neoplasm	1.56e-05	5.27e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MYC—peripheral nervous system neoplasm	1.56e-05	5.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTPN11—peripheral nervous system neoplasm	1.56e-05	5.26e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.54e-05	5.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.54e-05	5.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.53e-05	5.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.5e-05	5.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	5.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—peripheral nervous system neoplasm	1.49e-05	5.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NRAS—peripheral nervous system neoplasm	1.49e-05	5.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—peripheral nervous system neoplasm	1.48e-05	5e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.47e-05	4.98e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.46e-05	4.93e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.45e-05	4.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.44e-05	4.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.43e-05	4.84e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	4.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-05	4.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.42e-05	4.78e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.41e-05	4.77e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.4e-05	4.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—peripheral nervous system neoplasm	1.4e-05	4.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	4.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—peripheral nervous system neoplasm	1.38e-05	4.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NRAS—peripheral nervous system neoplasm	1.38e-05	4.65e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.36e-05	4.58e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HRAS—peripheral nervous system neoplasm	1.35e-05	4.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.34e-05	4.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB2—peripheral nervous system neoplasm	1.33e-05	4.5e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HRAS—peripheral nervous system neoplasm	1.33e-05	4.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.3e-05	4.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.29e-05	4.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MYC—peripheral nervous system neoplasm	1.28e-05	4.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.28e-05	4.33e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	1.28e-05	4.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.27e-05	4.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.27e-05	4.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.27e-05	4.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.25e-05	4.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HRAS—peripheral nervous system neoplasm	1.24e-05	4.2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.24e-05	4.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB2—peripheral nervous system neoplasm	1.23e-05	4.16e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HRAS—peripheral nervous system neoplasm	1.23e-05	4.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.19e-05	4.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-05	4.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—peripheral nervous system neoplasm	1.19e-05	4.02e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.17e-05	3.96e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—peripheral nervous system neoplasm	1.17e-05	3.96e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.17e-05	3.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.16e-05	3.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-05	3.9e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.15e-05	3.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	3.86e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-05	3.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.12e-05	3.8e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-05	3.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.11e-05	3.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-05	3.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—peripheral nervous system neoplasm	1.1e-05	3.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	3.69e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.09e-05	3.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HRAS—peripheral nervous system neoplasm	1.09e-05	3.69e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.09e-05	3.69e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—peripheral nervous system neoplasm	1.08e-05	3.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.05e-05	3.56e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.04e-05	3.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.03e-05	3.48e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.02e-05	3.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NRAS—peripheral nervous system neoplasm	1.01e-05	3.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HRAS—peripheral nervous system neoplasm	1.01e-05	3.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.65e-06	3.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.65e-06	3.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—peripheral nervous system neoplasm	9.64e-06	3.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.46e-06	3.2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.42e-06	3.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NRAS—peripheral nervous system neoplasm	9.36e-06	3.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.29e-06	3.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.25e-06	3.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—peripheral nervous system neoplasm	9.2e-06	3.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.11e-06	3.08e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.09e-06	3.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.99e-06	3.04e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.97e-06	3.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—peripheral nervous system neoplasm	8.9e-06	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.77e-06	2.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MYC—peripheral nervous system neoplasm	8.72e-06	2.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.71e-06	2.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.62e-06	2.91e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.58e-06	2.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.12e-06	2.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.82e-06	2.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.69e-06	2.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.58e-06	2.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—peripheral nervous system neoplasm	7.45e-06	2.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HRAS—peripheral nervous system neoplasm	7.42e-06	2.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.38e-06	2.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.35e-06	2.48e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.2e-06	2.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.19e-06	2.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.17e-06	2.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.06e-06	2.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.92e-06	2.34e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.89e-06	2.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HRAS—peripheral nervous system neoplasm	6.85e-06	2.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.77e-06	2.29e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.73e-06	2.27e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.67e-06	2.25e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.58e-06	2.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.56e-06	2.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—peripheral nervous system neoplasm	6.55e-06	2.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.52e-06	2.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.23e-06	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.11e-06	2.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.11e-06	2.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.08e-06	2.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—peripheral nervous system neoplasm	6.05e-06	2.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.98e-06	2.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.59e-06	1.89e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.47e-06	1.85e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.21e-06	1.76e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.09e-06	1.72e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.02e-06	1.69e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.8e-06	1.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.28e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.24e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.18e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.09e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.61e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.53e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.81e-06	9.5e-06	CbGpPWpGaD
